AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 23-E-02-028.01
CMS should monitor the use of buprenorphine and share information, as appropriate, with Departmental partners.
The recommendation, in the publisher's words
CMS should monitor the use of buprenorphine and share information, as appropriate, with Departmental partners.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- May 16, 2023
- Report
- The Risk of Misuse and Diversion of Buprenorphine for Opioid Use Disorder Appears to Be Low in Medicare Part D (OEI-02-22-00160) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Partial Concur (as recorded by the publisher)
- Last update received
- September 3, 2026
- Next update expected
- October 5, 2027 (publisher's date)
- Publisher topics
- Prescription Drug, Public Health Issues, Substance Abuse Disorder
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
3 more, of which 0 are open in the publisher's file.
- CMS should inform providers about buprenorphine use and the low risk of diversion to encourage providers to treat more Part D enrollees who have opioid use disorder.HHS OIG 23-E-02-028.02 · issued May 16, 2023 · closed May 15, 2024Closed Implemented
- CMS should take steps to inform providers about the availability of buprenorphine combination products in Part D, which can minimize the risk of misuse and diversion.HHS OIG 23-E-02-028.03 · issued May 16, 2023 · closed May 15, 2024Closed Implemented
- CMS should follow up on the prescribers with concerning patterns identified in this report.HHS OIG 23-E-02-028.04 · issued May 16, 2023 · closed Jan 24, 2024Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.